← Mechanisms of action
RNA
NUCLEIC-ACIDHomo sapiens
Drugs acting on this target (12)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| Aspacytarabine | Disrupting agent | experimental | Small molecule | RNA disrupting agent |
| Doxifluridine (furtulon) | Disrupting agent | experimental | Small molecule | RNA disrupting agent |
| rslv-132 | Hydrolytic enzyme | experimental | Recombinant protein | RNA hydrolytic enzyme |
| azacitidine (vidaza) | Inhibitor | approved | Small molecule | RNA inhibitor |
| capecitabine (xeloda) | Inhibitor | approved | Small molecule | RNA inhibitor |
| carmustine (bicnu) | Inhibitor | approved | Small molecule | RNA inhibitor |
| cytarabine (cytosar-u) | Inhibitor | approved | Small molecule | RNA inhibitor |
| elacytarabine | Inhibitor | experimental | Small molecule | RNA inhibitor |
| fluorouracil (efudex) | Inhibitor | approved | Small molecule | RNA inhibitor |
| hydroxystilbamidine isetionate | Inhibitor | approved | Small molecule | RNA inhibitor |
| tegafur | Inhibitor | experimental | Small molecule | RNA inhibitor |
| trifluorouracil | Inhibitor | experimental | Small molecule | RNA inhibitor |